Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Switch or Maintenance of Renin-Angiotensin System Inhibitors in Patients With Covid-19: A Randomized Proof of Concept Trial

NCT04493359 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT04493359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04493359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Switch or Maintenance of Renin-Angiotensin System Inhibitors in Patients With Covid-19: A Randomized Proof of Concept Trial
Lead sponsor
University of Sao Paulo
Phase
Phase 2/3
Overall status
Terminated
Start date
July 25, 2020
Completion date
September 28, 2021
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angiotensin ii receptor antagonist adverse reaction, covid19